Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
On Oct. 9, 2025, Beicheng Sun at Anhui Medical University in China and his colleagues have reported the…
On Oct. 8, 2025, The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in…
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
On Oct. 6, 2025, the World Health Organization (WHO) reported world is smoking less, but the tobacco epidemic…
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
On Oct. 6, 2026, The Nobel Assembly has awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E….
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…
On Oct. 2, 2025, researchers in McGill’s Department of Physics announced they have developed a new device that can trap…
On Oct. 2, 2025, the South Carolina Department of Public Health )DPH) has confirms a measles outbreak in…
On Oct. 2, 2025, the U.S. Food and Drug Administration (FDA) approved Evita Solution’s generic version of the…
On Oct. 1, 2025, researchers excavating a site known as Schöningen in northern Germany reported finding 300,000-year-old genes,…
On Sept. 30, 2025, Pfizer announced an agreement with the Trump Administration that will ensure U.S. patients pay…
On Sept. 30, 2025, Zoetis announced that Dectomax®-CA1 Injectable is the first and only parasite control product to…
On Sept. 26, 2025, Sanofi US announced a broad expansion of its Insulins Valyou Savings Program by offering…
On Sept. 26, 2025, Amgen announced a $650 million expansion of its U.S. manufacturing network in Puerto Rico,…
On Sept. 26, 2025,Eli Lilly and announced the official opening of its newest Lilly Gateway Labs (LGL) site…
On Sept. 25, 2025, the National Institutes of Health (NIH) announced the award of contracts for launching the…
On Sept. 25, 2025, The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million…
On Sept. 25, 2025, Final data from a landmark clinical trial in patients with an aggressive form of…
On Sept. 25, 2025, Glaukos, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
On Sept. 25, 2025, Biolinq, a pioneering developer of precision multi-analyte biosensors to improve metabolic health, announced the…
On Sept. 24, 2025, a global clinical trial for a new Huntington’s disease treatment has posted positive results,…
On Sept. 24, 2025, an ambitious and revolutionary initiative aims to map every cell of all eukaryotic life…
On Sept. 24, 2025, Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs announced they will sell generic versions…
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…